Halozyme's Transformative Acquisition of Evotec: A Strategic Move for Growth and Market Expansion

TipRanksNov 20 09:25 ET

Is Evotec SE (EVO) the Best German Stock to Buy Now?

Yahoo FinanceNov 19 18:01 ET

Evotec Plunges Amid Report It's Against Halozyme Therapeutics Takeover

Seeking AlphaNov 19 08:47 ET

Deutsche Bank Remains a Sell on Evotec (0IRF)

TipRanksNov 18 06:55 ET · Ratings

Halozyme Therapeutics (HALO.US) plans to acquire Evotech (EVO.US) for 2.1 billion dollars in cash.

Halozyme Therapeutics financed the acquisition of German company Evotec for 2 billion euros (equivalent to 2.1 billion dollars) in cash.

Zhitong FinanceNov 18 01:34 ET

Halozyme Plans Finance $2.1 Takeover of Evotech in Cash: Report

Seeking AlphaNov 17 18:28 ET